Novavax (NVAX) Covid-19 Vaccine Induces Immune Response in First Human Study, Company Says - DJ
Go back to Novavax (NVAX) Covid-19 Vaccine Induces Immune Response in First Human Study, Company Says - DJ| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.22 +0.22 (2.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.00 | 52 Week High | $9.23 | |||
| Open | $9.15 | 52 Week Low | $1.16 | |||
| Day High | $9.36 | P/E | N/A | |||
| Day Low | $9.09 | EPS | $-0.30 | |||
| Volume | 618,570 | |||||

